Di Lorenzo, Giuseppe
 Distribuzione geografica
Continente #
AS - Asia 2.348
SA - Sud America 970
NA - Nord America 576
EU - Europa 231
AF - Africa 81
OC - Oceania 4
Totale 4.210
Nazione #
SG - Singapore 1.177
BR - Brasile 818
US - Stati Uniti d'America 391
CN - Cina 377
HK - Hong Kong 361
VN - Vietnam 216
MX - Messico 134
IT - Italia 92
AR - Argentina 47
BD - Bangladesh 32
ID - Indonesia 27
GB - Regno Unito 26
IN - India 25
EC - Ecuador 24
IQ - Iraq 24
CA - Canada 21
NL - Olanda 20
VE - Venezuela 19
DE - Germania 18
SA - Arabia Saudita 18
ZA - Sudafrica 18
TR - Turchia 17
CO - Colombia 16
PY - Paraguay 16
UA - Ucraina 15
MA - Marocco 14
UZ - Uzbekistan 14
RU - Federazione Russa 13
EG - Egitto 12
KE - Kenya 10
PK - Pakistan 10
CL - Cile 9
UY - Uruguay 9
JO - Giordania 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 6
FR - Francia 6
TN - Tunisia 6
CH - Svizzera 5
DZ - Algeria 5
ES - Italia 5
ET - Etiopia 5
JM - Giamaica 5
LB - Libano 5
PE - Perù 5
PT - Portogallo 5
AL - Albania 4
BY - Bielorussia 4
KZ - Kazakistan 4
OM - Oman 4
TT - Trinidad e Tobago 4
AU - Australia 3
AZ - Azerbaigian 3
BB - Barbados 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KG - Kirghizistan 3
NP - Nepal 3
PA - Panama 3
PS - Palestinian Territory 3
BH - Bahrain 2
BS - Bahamas 2
CZ - Repubblica Ceca 2
FI - Finlandia 2
GR - Grecia 2
IL - Israele 2
LI - Liechtenstein 2
RS - Serbia 2
AT - Austria 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GF - Guiana Francese 1
GN - Guinea 1
HT - Haiti 1
IR - Iran 1
IS - Islanda 1
JP - Giappone 1
KR - Corea 1
KY - Cayman, isole 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
MR - Mauritania 1
MY - Malesia 1
NC - Nuova Caledonia 1
PL - Polonia 1
RO - Romania 1
SE - Svezia 1
SV - El Salvador 1
YE - Yemen 1
YT - Mayotte 1
ZW - Zimbabwe 1
Totale 4.210
Città #
Singapore 619
Hong Kong 345
Beijing 141
Mexico City 119
Ashburn 115
Ho Chi Minh City 87
São Paulo 53
Hanoi 46
Rome 28
Rio de Janeiro 22
Brasília 18
Haiphong 17
Belo Horizonte 14
Naples 14
Campinas 13
Chicago 13
Tashkent 13
Salvador 12
Curitiba 11
Baghdad 9
Goiânia 9
Porto Alegre 9
Amman 8
Dhaka 8
Montevideo 8
Nairobi 8
Santo André 8
Boardman 7
Fortaleza 7
Guayaquil 7
Johannesburg 7
Milan 7
New York 7
Quito 7
Ribeirão Preto 7
Sorocaba 7
Uberlândia 7
Cape Town 6
Casablanca 6
Contagem 6
Jeddah 6
João Pessoa 6
Asunción 5
Belford Roxo 5
Belém 5
Cairo 5
Caracas 5
Cleveland 5
Guarulhos 5
Istanbul 5
Joinville 5
Lahore 5
Manaus 5
Mauá 5
Ninh Bình 5
Phủ Lý 5
Riyadh 5
Barquisimeto 4
Biên Hòa 4
Bragança Paulista 4
Buenos Aires 4
Charlotte 4
Da Nang 4
Dubai 4
Franca 4
Itapema 4
Itaquaquecetuba 4
Juiz de Fora 4
Jundiaí 4
La Paz 4
Limeira 4
Maricá 4
Nepean 4
Novo Hamburgo 4
Philadelphia 4
Praia Grande 4
Sete Lagoas 4
Suzano 4
Taubaté 4
Toronto 4
Vancouver 4
Addis Ababa 3
Anaheim 3
Ankara 3
Atlanta 3
Baku 3
Balneário Camboriú 3
Baltimore 3
Blumenau 3
Bridgetown 3
Canoas 3
Caxias do Sul 3
Colíder 3
Córdoba 3
Dallas 3
Dammam 3
Delhi 3
Divinópolis 3
Erbil 3
Francisco Morato 3
Totale 2.095
Nome #
Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients 49
Clinical characteristics of metastatic prostate cancer patients infected with COVID-19 in South Italy 29
A case of renal melanoma metastasis: Description of clinico-pathological features 28
The use of tamsulosin in the medical treatment of ureteral calculi: Where do we stand? 23
Development and Validation of the PREVESMED Questionnaire: A Comprehensive Tool for Assessing Adherence to a Mediterranean Lifestyle 23
Management of AIDS-related Kaposi's sarcoma 22
Validation of Psychometric Tools for Assessing Fatigue, Mood, and Sleep Quality: Application in the PREVES-STOP Study. 22
KIDNEY CANCER Overall survival is an unsuitable primary end point 21
Prostate Cancer Detection in the "Grey Area" of Prostate-Specific Antigen Below 10 ng/ml: Head-to-Head Comparison of the Updated PCPT Calculator and Chun's Nomogram, Two Risk Estimators Incorporating Prostate Cancer Antigen 3 20
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers 20
Instant messaging in cancer care 19
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis 19
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: A phase II study 19
Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy 19
Paclitaxel in Pretreated Metastatic Penile Cancer: Final Results of a Phase 2 Study 19
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 18
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 18
Expression of HECA-452 in parapsoriasis and mycosis fungoides 18
PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study 18
The Impact of Routine Molecular Screening for SARS-CoV-2 in Patients Receiving Anticancer Therapy: An Interim Analysis of the Observational COICA Study 18
DOCETAXEL AND CARBOPLATIN IN DOCETAXEL PRETREATED CASTRATION-RESISTANT PROSTATE CANCER: PRELIMINARY RESULTS 18
Docetaxel Rechallenge in a Heavily Pretreated Patient with Castration-Resistant Prostate Cancer 18
Impact of Dietary Supplements on Clinical Outcomes and 2 Quality of Life in Patients with Breast Cancer: A Systematic Review 18
Focus on localized laryngeal amyloidosis: Management of five cases 18
Chirurgia conservativa e qualità di vita in pazienti con carcinoma renale localizzato. 18
A comprehensive outlook on intracerebral therapy of malignant gliomas. 18
A Retrospective Study of Cemiplimab Effectiveness in Elderly Patients with Squamous Cell Carcinoma of the Skin: Insights from a Real-Life Scenario 18
Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer 17
LOOKING AT THE PROSTATES OF PATIENTS WITH BLADDER CANCER: A THOUGHTFUL EXERCISE 17
An evolving role for immunotherapy in metastatic RCC 17
Immunotherapy for the treatment of prostate cancer 17
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 17
Expression of proto-oncogene c-kit in high risk prostate cancer 17
Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen 17
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 17
New perspectives in the therapy of castration resistant prostate cancer 17
Optimal management of a patient with recurrent nasopharyngeal carcinoma 17
Re: Matthew R. Smith, Maha Hussain, Fred Saad, et al. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. N Engl J Med. 2022;386:1132–1142 17
New Agents for Prostate Cancer. 17
Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients 17
A Challenging Surgical Approach to Locally Advanced Primary Urethral Carcinoma: A Case Report and Literature Review 17
A Prognostic Model for Patients With Metastatic Renal Cell Cancer: What's New? 17
A complete response with rituximab in metastatic diffuse large B-cell lymphoma of the testis: case report 17
INCREASED EXPRESSION OF THE AUTOCRINE MOTILITY FACTOR IS ASSOCIATED WITH POOR PROGNOSIS IN PATIENTS WITH CLEAR CELL – RENAL CELL CARCINOMA 17
Development and validation of the PREVES-HOR Questionnaire: a patient-reported measure of hormone-therapy–related quality of life in prostate-cancer patients undergoing androgen-deprivation therapy 17
Predicting early and delayed bleedings in children who undergo adeno-tonsillectomy surgery. Is it really possible? 17
Predictors of outcomes in patients with EGFR-mutated non-small cell lung cancer receiving EGFR tyrosine kinase inhibitors: A systematic review and meta-analysis 17
Efficacy of Sunitinib Rechallenge in Kidney Cancer: Are mTOR Inhibitors Involved or Is It Only a Matter of Time? 17
Neuroendocrine immunophenotype as predictor of clinical recurrence in 110 patients with prostate cancer 17
Effect of baseline characteristics on cabazitaxel treatment duration in patients with metastatic castration-resistant prostate cancer (mCRPC): a post hoc analysis of the compassionate use (CUP)/expanded access programs (EAP) and CAPRISTANA registry 17
Kaempferol, myricetin and fisetin in prostate and bladder cancer: A systematic review of the literature 16
Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience 16
It is no longer the time to disregard thyroid metastases from breast cancer: a case report and review of the literature 16
Predictors of Residual T1 High Grade on Re- Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer 16
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: a systematic review and meta-analysis 16
Adrenalectomy: defining its role in the surgical treatment of renal cell carcinoma. 16
Involvement of growth factor receptors of the epidermal growth factor receptor (EGFR) family in prostate cancer development and in the progression to androgen- independence. 16
The Effect of Vaccination against COVID-19 in Cancer Patients: Final Results of the COICA Trial 16
Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection 16
Gemcitabine Versus Bacille Calmette-Guerin After Initial Bacille Calmette-Guerin Failure in Non-Muscle-Invasive Bladder Cancer A Multicenter Prospective Randomized Trial 16
Numerical study of laminar confined impinging slot jets with nanofluids 16
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 16
Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy 16
Thermal and fluid dynamic behaviors of confined laminar impinging slot jets with nanofluids 16
Outcomes associated with first-line PD-1 and PD-L1 inhibitors vs. sunitinib in patients with renal cell cancer with sarcomatoid features: a systematic review and meta-analysis 16
Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis 16
Computed-Tomography-Structured Reporting in Middle Ear Opacification: Surgical Results and Clinical Considerations From a Large Retrospective Analysis 16
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis 16
Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial 16
The role of immunotherapy in oncology 16
Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer 16
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: A retrospective Italian survey 16
Novel Chemotherapy-Sparing Approach for HER2-Low, ER-Positive Breast Cancer: Combining Trastuzumab Deruxtecan with Endocrine Therapy 16
ADVERSE EVENTS 1 OF IMMUNE CHECKPOINT INHIBITORS THERAPYFOR UROLOGIC CANCER PATIENTS IN CLINICAL TRIALS: A COLLABORATIVE SYSTEMATIC REVIEW AND META ANALYSIS 16
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors 16
Cisplatin- Versus Non-Cisplatin-based First-Line Chemotherapy for Advanced Urothelial Carcinoma Previously Treated With Perioperative Cisplatin 16
READY: Real-world data from an Italian compassionate use program of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC) 16
Dysregulated metabolism: A relevant player in prostate cancer progression and clinical management 16
Words of Wisdom. Re: Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy 16
Kaempferol, myricetin and fisetin in prostate and bladder cancer: a systematic review of literature 16
Activity of platinum-based chemotherapy in advanced prostate cancer patients with and without DNA repair gene aberrations: An International Collaborative Analysis 16
Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer - A multi-institutional, long-term experience 16
Bio-inspired method for advanced industrial sludge treatment with closed cycle drying process 16
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 15
Thalidomide in combination with oral daily cyclophosphamide in patients with pretreated hormone refractory prostate cancer: A phase I clinical trial 15
Squamous cell carcinoma of the scrotum: A look beyond the chimneystacks 15
Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: A multicenter study 15
Impact of previous nephrectomy on clinical outcome of metastatic renal carcinoma treated with immune-oncology (I-O). A real-world study on behalf of Meet-URO group (MeetUro-7b) 15
Real-world experience with cabazitaxel in patients with metastatic castration-resistant prostate cancer: a final, pooled analysis of the compassionate use programme and early access programme 15
Hypercastration in prostate cancer 15
Metastatic Renal Cell Carcinoma: Recent Advances in the Targeted Therapy Era 15
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 15
Synergistic Combination of Quercetin and Mafosfamide in the Treatment of Bladder Cancer Cells 15
Dynamic sentinel node biopsy in clinically node-negative penile cancer versus radical inguinal lymphadenectomy: a comparative study 15
Combination therapy for metastatic renal cell carcinoma 15
Everolimus as second-line therapy for metastatic renal cell carcinoma: a 'real-life' study 15
The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer 15
Vesicourethral anastomosis during radical retropubic prostatectomy: Does the number of sutures matter? 14
Testicular cancer from diagnosis to epigenetic factors 14
Long lasting response to second-line everolimus in kidney cancer. 14
Totale 1.739
Categoria #
all - tutte 28.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20252.165 0 0 0 28 338 19 114 372 101 60 553 580
2025/20262.412 266 27 355 434 922 408 0 0 0 0 0 0
Totale 4.577